Search

Your search keyword '"Gordon, Paul H."' showing total 285 results
Start Over Author "Gordon, Paul H."
285 results on '"Gordon, Paul H."'

1. Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.

Author

Gwinn, Katrina, Corriveau, Roderick A, Mitsumoto, Hiroshi, Bednarz, Kate, Brown, Robert H, Cudkowicz, Merit, Gordon, Paul H, Hardy, John, Kasarskis, Edward J, Kaufmann, Petra, Miller, Robert, Sorenson, Eric, Tandan, Rup, Traynor, Bryan J, Nash, Josefina, Sherman, Alex, Mailman, Matthew D, Ostell, James, Bruijn, Lucie, Cwik, Valerie, Rich, Stephen S, Singleton, Andrew, Refolo, Larry, Andrews, Jaime, Zhang, Ran, Conwit, Robin, Keller, Margaret A, and ALS Research Group

Subjects
ALS Research Group, Cell Line, Transformed, Humans, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Genetic Predisposition to Disease, Case-Control Studies, Chromosome Mapping, Genotype, Phenotype, Polymorphism, Single Nucleotide, Genome, Human, Databases, Genetic, Clinical Research, Brain Disorders, Genetics, Neurodegenerative, Human Genome, Biotechnology, ALS, Rare Diseases, Neurosciences, 2.1 Biological and endogenous factors, Neurological, Generic health relevance, General Science & Technology
Abstract

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is currently incurable and treatment is largely limited to supportive care. Family history is associated with an increased risk of ALS, and many Mendelian causes have been discovered. However, most forms of the disease are not obviously familial. Recent advances in human genetics have enabled genome-wide analyses of single nucleotide polymorphisms (SNPs) that make it possible to study complex genetic contributions to human disease. Genome-wide SNP analyses require a large sample size and thus depend upon collaborative efforts to collect and manage the biological samples and corresponding data. Public availability of biological samples (such as DNA), phenotypic and genotypic data further enhances research endeavors. Here we discuss a large collaboration among academic investigators, government, and non-government organizations which has created a public repository of human DNA, immortalized cell lines, and clinical data to further gene discovery in ALS. This resource currently maintains samples and associated phenotypic data from 2332 MND subjects and 4692 controls. This resource should facilitate genetic discoveries which we anticipate will ultimately provide a better understanding of the biological mechanisms of neurodegeneration in ALS.

Published
2007

6. List of Contributors

Author

Abbatecola, Angela Marie, primary, Abe, Koji, additional, Abisambra, Jose F., additional, Ahmad, Aliya, additional, Alaei, Hojjatollah, additional, Alagiakrishnan, Kannayiram, additional, Aliev, Gjumrakch, additional, Allegri, Ricardo Francisco, additional, Almeida, Osvaldo P., additional, Álvarez-Cervera, Fernando J., additional, Alwi, Nor Amalina Ahmad, additional, Ames, David, additional, Anderson-Mooney, Amelia Jane, additional, Andrade, José Paulo, additional, Anglés, Neus, additional, Armstrong, R.A., additional, Assunção, Marco, additional, Atteia, Hebatallah Husseini, additional, Avila, Marco Fidel, additional, Bair, Ming-Jong, additional, Barbagallo, Mario, additional, Barberger-Gateau, Pascale, additional, Barbieri, Michelangela, additional, Barreto, George E., additional, Bata-García, José L., additional, Begum, Monirun, additional, Bellia, Francesco, additional, Belvedere, Mario, additional, Bennett, Louise E., additional, Białecka, Monika, additional, Bird, Michael, additional, Blundo, Carlo, additional, Boccardi, Virginia, additional, Bolea, Irene, additional, Bosco, Domenico, additional, Brouwer-Brolsma, Elske M., additional, Brust, John C.M., additional, Buffa, Roberto, additional, Bunner, Kendra D., additional, Burri, Lena, additional, Cabezas, Ricardo, additional, Camina, María Alicia, additional, Campbell, Tessa N., additional, Cano, Lourdes Rexach, additional, Chen, Huan-Lin, additional, Chen, Jianmin, additional, Cheung, David Wing-Shing, additional, Choy, Francis Y.M., additional, Chua, J., additional, Colica, Carmen, additional, Corcia, Philippe, additional, Craft, Suzanne, additional, Cristiano, Dario, additional, Cusimano, Michael D., additional, Dalton, Kate, additional, Davidson, Terry L., additional, De Bartolo, Matteo, additional, de Bem, Andreza Fabro, additional, de Castro, Isac, additional, de Groot, Lisette C.P.G.M., additional, de la Cruz Marcos, Sandra, additional, de Oliveira, Jade, additional, del Balzo, Valeria, additional, Deguchi, Kentaro, additional, Deguchi, Shoko, additional, Deth, Richard, additional, Dominguez, Ligia J., additional, Donini, Lorenzo M., additional, Doruk, Huseyin, additional, Dziewas, Rainer, additional, Díes, Rafael Carles, additional, El-Bachá, Ramon Santos, additional, El-Swefy, Sahar Elsayed, additional, Enciso, Laura Carreño, additional, Ermio, Caterina, additional, Escribano, Begoña M., additional, Estrada-Sánchez, Ana María, additional, Etgen, Thorleif, additional, Farina, Marcelo, additional, Fava, Antonietta, additional, Feart, Catherine, additional, Feng, Lei, additional, Fernández-Fernández, Laura, additional, Ferreira, Danilio Alvear Sampaio, additional, Fiala, Milan, additional, Fialdini, Renata Caruso, additional, Fisher, Cheryl, additional, Galimberti, Daniela, additional, Galvin, James E., additional, Gelber, Rebecca P., additional, Gerace, Carmela, additional, Giannakopoulos, Panteleimon, additional, Giannopoulos, Phillip F., additional, Giridharan, Vijayasree V., additional, Giusti, Anna Maria, additional, Gonzalez, Janneth, additional, Góngora-Alfaro, José L., additional, Gordon, Paul H., additional, Greiwe, Jeffrey S., additional, Grima, Natalie A., additional, Guedes, Rubem, additional, Gupta, Susham, additional, Gyengesi, Erika, additional, Haller, Sven, additional, Hanson, Angela J., additional, Harvey, Jenni, additional, Hassan, Ossama Morsi, additional, Henderson, Samuel T., additional, Herrup, Karl, additional, Hickey, M.A., additional, Hoerr, Robert, additional, Hou, Xiaoli, additional, Huang, Chengyu, additional, Hügel, Helmut M., additional, Hwang, Sam-Long, additional, Ikeda, Yoshio, additional, Irie, Kazuhiro, additional, Jack, Alexandria, additional, Jackson, Neale, additional, Jackson, Richard L., additional, Jannise, Brittany, additional, Jiang, Yugang, additional, Johnson, C.Shanthi, additional, Jolliff, James S., additional, Jové, Mariona, additional, Kam, Jonathan S., additional, Kanoski, Scott E., additional, Khan, Khurshid, additional, Kimura, Takemi, additional, Kitagishi, Yasuko, additional, Konishi, Tetsuya, additional, Kovacs, Gabor G., additional, Krause, Debra, additional, Kua, Ee-Heok, additional, Kurata, Tomoko, additional, Kurian, Mini, additional, Kwok, Timothy, additional, Lam, Wai Ping, additional, Lattanzio, Fabrizia, additional, Lawrence, Catherine B., additional, Lee, Tih-Shih, additional, Lee, Yuan-Kai, additional, Leslie, Paula, additional, Leung, Ping Chung, additional, Li, Runping, additional, Liang, Willmann, additional, Lim, Siong-Meng, additional, Lin, Fengwu, additional, Lin, I-Tsung, additional, Loef, Martin, additional, Lovblad, Karl-Olof, additional, Luque, Evelio, additional, Luz, Protásio Lemos da, additional, Macaulay, S.Lance, additional, Madan, Swati, additional, Maetzler, Walter, additional, Mahendran, R., additional, Majeed, Abu Bakar Abdul, additional, Mander, Alastair G., additional, Mani, Vasudevan, additional, Manley, Graham, additional, Manor, Danny, additional, Margetts, Christine, additional, Marini, Elisabetta, additional, Martin-Fernandez, J.Javier, additional, Martínez-Martos, José Manuel, additional, Martínez, Irene Villegas, additional, de Mateo Silleras, Beatriz, additional, Matsuda, Satoru, additional, May, Brian H., additional, McGirr, Alexander, additional, McCormick, Laurie M., additional, Mehta, Jatin, additional, Mereu, Elena, additional, Messina, Antonino, additional, Minami, Akari, additional, Mirowsky, John, additional, Moore, Eileen M., additional, Moreira, Eduardo Luiz Gasnhar, additional, Morelló, José Ramón, additional, Mori, Takashi, additional, Münch, Gerald, additional, Murakami, Kazuma, additional, Mutter, Joachim, additional, Naharci, Mehmet Ilkin, additional, Nakao, Frank Shigeo, additional, Ng, Tze-Pin, additional, Nigro, Julie, additional, Ninomiya, Toshiharu, additional, Nishiyama, Marcelo, additional, Nomani, Erum, additional, Nooyens, Astrid C.J., additional, Oda, Adriana Leico, additional, Okamura, Hitoshi, additional, Oliveira, Acary Souza Bulle, additional, Ono, Yuna, additional, Orsitto, Giuseppe, additional, Ozawa, Mio, additional, Pallet, Véronique, additional, Pamplona, Reinald, additional, Paolisso, Giuseppe, additional, Paradiso, Sergio, additional, Pase, Matthew P., additional, Patki, Gaurav, additional, Piguet, Olivier, additional, Pinto, Alessandro, additional, Pirritano, Domenico, additional, Plastino, Massimiliano, additional, Poggiogalle, Eleonora, additional, Polidori, M.Cristina, additional, Polimanti, Renato, additional, Portero-Otin, Manuel, additional, Power, Brian D., additional, Praticò, Domenico, additional, Prediger, Rui Daniel S., additional, Preedy, Victor R., additional, Prendergast, Mark A., additional, Rae, Daniela, additional, Ramasamy, Kalavathy, additional, Ramli, Muhammad Zaki, additional, Ramirez, Bartolomé, additional, Ramírez-Expósito, María Jesús, additional, Rebec, George V., additional, Reddy, V.Prakash, additional, Redondo del Río, María Paz, additional, Reguant, Jordi, additional, Reisi, Parham, additional, Remington, Ruth, additional, Ricci, Monica, additional, Rizzarelli, Enrico, additional, Robinson, Stephen R., additional, Rogers, Eugene, additional, Rosini, Francesca, additional, Roupas, Peter, additional, Rufa, Alessandra, additional, Russo, María Julieta, additional, Sahathevan, Ramesh, additional, Salim, Samina, additional, Salvioni, Cristina Cleide dos Santos, additional, Sample, Camille H., additional, Santamaría, Abel, additional, Saqqur, Maher, additional, Saragat, Bruno, additional, Sauvant, Julie, additional, Sauvant, Patrick, additional, Scarpini, Elio, additional, Scelza, M.F.Z., additional, Schwen, Richard J., additional, Self, Rachel L., additional, Serrano, José C.E., additional, Shea, Thomas B., additional, Shih, Ping-Hsiao, additional, Shimizu, Takahiko, additional, Shunichiro, Shinagawa, additional, Siahmard, Zahra, additional, Sławek, Jarosław, additional, Smoliner, Christine, additional, Solé, Montse, additional, Sprini, Delia, additional, Squitti, Rosanna, additional, Srulijes, Karin, additional, Stahl, Wilhelm, additional, Stanich, Patricia, additional, Stephens, Brian R., additional, Sun, Mingxue, additional, Takamatsu, Junichi, additional, Tang, Hong Chai, additional, Thandavarayan, Rajarajan A., additional, Torrente, Daniel, additional, Town, Terrence, additional, Túnez, Isaac, additional, Ulatowski, Lynn, additional, Unzeta, Mercedes, additional, Valente, Tony, additional, van Keizerswaard, Jolanda, additional, van de Rest, Ondine, additional, van der Zwaluw, Nikita L., additional, Vecchio, Graziella, additional, Veiga, Judith Jimenez, additional, Vila-Rodriguez, Fidel, additional, Walach, Harald, additional, Warnecke, Tobias, additional, Watters, David A.K., additional, Weber, Wolfgang, additional, Weitzman, Rachel, additional, White, Lon R., additional, Wirth, Rainer, additional, Wu, Chia-Hsien, additional, Xiao, Kai, additional, Xue, Charlie C.L., additional, Yen, Gow-Chin, additional, Yew, David Tai-Wai, additional, Yokoi, Teruo, additional, Zhang, Anthony L., additional, Zhang, Lihong, additional, and Zito, Giancarlo, additional

Published
2015
Full Text
View/download PDF

14. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Author

Gordon, Paul H, Moore, Dan H, Miller, Robert G, Florence, Julaine M, Verheijde, Joseph L, Doorish, Carolyn, Hilton, Joan F, Spitalny, G Mark, MacArthur, Robert B, Mitsumoto, Hiroshi, Neville, Hans E, Boylan, Kevin, Mozaffar, Tahseen, Belsh, Jerry M, Ravits, John, Bedlack, Richard S, Graves, Michael C, McCluskey, Leo F, Barohn, Richard J, and Tandan, Rup

Published
2007
Full Text
View/download PDF

16. A Rare Motor Neuron Deleterious Missense Mutation in the DPYSL3 (CRMP4) Gene is Associated with ALS

Author

Blasco, Hélène, Bernard-Marissal, Nathalie, Vourcʼh, Patrick, Guettard, Yves Olivier, Sunyach, Claire, Augereau, Olivier, Khederchah, Joelle, Mouzat, Kevin, Antar, Catherine, Gordon, Paul H., Veyrat-Durebex, Charlotte, Besson, Gérard, Andersen, Peter M., Salachas, François, Meininger, Vincent, Camu, William, Pettmann, Brigitte, Andres, Christian R., and Corcia, Philippe

Published
2013
Full Text
View/download PDF

20. Translational Research in ALS

Author

Montes, Jacqueline, primary, Bendotti, Caterina, additional, Tortarolo, Massimo, additional, Cheroni, Cristina, additional, Hallak, Hussein, additional, Speiser, Zipora, additional, Goren, Sari, additional, Blaugrund, Eran, additional, and Gordon, Paul H., additional

Published
2008
Full Text
View/download PDF

21. List of Contributors

Author

Acosta, M., primary, Bendotti, Caterina, additional, Blaugrund, Eran, additional, Brunner, Daniela, additional, Borsini, Franco, additional, Cheroni, Cristina, additional, Chesselet, Marie-Françoise, additional, Deadwyler, Sam A., additional, Elgersma, Y., additional, Fahn, Stanley, additional, Gordon, Paul H., additional, Goren, Sari, additional, Goumeniouk, Alexander D., additional, Hallak, Hussein, additional, Hampson, Robert E., additional, Hannan, F., additional, Hardt, M., additional, Hu, Shu-Ching, additional, Hunter, A. Jackie, additional, Hunter-Schaedle, K., additional, Klitgaard, Henrik, additional, Krab, L.C., additional, Leavitt, Blair R., additional, Legius, E., additional, Li, Weidong, additional, Lindner, Mark D., additional, Matagne, Alain, additional, McArthur, Robert A., additional, Menalled, Liliana, additional, Merchant, Kalpana M., additional, Montes, Jacqueline, additional, Schachter, Steven C., additional, Schneider, Lon S., additional, Shilyansky, Carrie, additional, Silva, Alcino J., additional, Speiser, Zipora, additional, Tariot, Pierre N., additional, Tortarolo, Massimo, additional, Wagner, Laura A., additional, White, H. Steve, additional, Wiltgen, B., additional, and Willner, Paul, additional

Published
2008
Full Text
View/download PDF

28. Amyotrophic Lateral Sclerosis With Ragged-Red Fibers

Author

Hirano, Michio, Angelini, Corrado, Montagna, Pasquale, Hays, Arthur P., Tanji, Kurenai, Mitsumoto, Hiroshi, Gordon, Paul H., Naini, Ali B., DiMauro, Salvatore, and Rowland, Lewis P.

Published
2008

34. Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis

Author

Veyrat-Durebex, Charlotte, primary, Corcia, Philippe, additional, Piver, Eric, additional, Devos, David, additional, Dangoumau, Audrey, additional, Gouel, Flore, additional, Vourc’h, Patrick, additional, Emond, Patrick, additional, Laumonnier, Frédéric, additional, Nadal-Desbarats, Lydie, additional, Gordon, Paul H, additional, Andres, Christian R, additional, and Blasco, Hélène, additional

Published
2015
Full Text
View/download PDF

35. Pure cerebellar ataxia linked to large C9orf72 repeat expansion

Author

Corcia, Philippe, primary, Vourc’h, Patrick, additional, Guennoc, Anne-Marie, additional, Del Mar Amador, Maria, additional, Blasco, Hélène, additional, Andres, Christian, additional, Couratier, Philippe, additional, Gordon, Paul H., additional, and Meininger, Vincent, additional

Published
2015
Full Text
View/download PDF

36. Amyotrophic lateral sclerosis : mortality and predictors of survival

Author

Gordon, Paul H., CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris VI, and Vincent MEININGER

Subjects
survie, épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, mortalité, maladie du motoneurone, prédicteurs de survie, sclérose latérale amyotrophique
Abstract

Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction of motor neurons, and to death of the patient in less than three years from symptom-onset. Better characterization of the epidemiology of ALS could improve understanding of the disease and lead to etiologic hypotheses, determine whether patterns of occurrence are changing, and show whether distinct phenotypes exist that could be examined for distinct causes. First, we examined the mortality rate from motor neuron disease in France from 1968 to 2007. The crude mortality rate over the study period was 1.74/100,000 person-years, and was higher in men than women. Mortality peaked between 75 and 79 years of age. The Standardized mortality ratio, after indirect standardization for age and gender, increased from 0.54 (95% CI = .49-.59) in 1968 to 1.26 (95% CI =1.20, 1.32) in 2007. The increasing mortality from MND was better explained by a cohort effect, which involves all individuals born at the same time, independent of their age at death, than by a period effect. Changing environmental exposures are a possible explanation for cohort effects, and could be examined in future studies. Next we analyzed survival rates and predictors of survival at the ALS Center, Salpêtrière Hospital, focusing on the survival rate during 2002-2009, and predictors of survival in 1995-2009. No single clinical factor best predicted survival, but a combination of variables (limb-onset, long duration between symptom-onset and first visit, and high muscle strength) were associated with longer survival. The survival rate improved significantly at the center after 2006.; La sclérose latérale amyotrophique ou SLA est une affection neurodegenerative conduisant à la mort des motoneurones, et responsable du décès des patients en moins de trois ans après la survenue des premiers symptômes. En l'absence de la découverte des causes chez la plupart des patients a considérablement pesé dans les difficultés que nous rencontrons pour découvrir un nouveau traitement. Une meilleure approche de l'épidémiologie pourrait permettre d'améliorer la connaissance de la maladie et pourrait offrir la possibilité de mieux formuler les hypothèses physio pathologiques possibles. Dans un premier temps, nous avons etudié le taux de mortalité de la SLA en France entre 1968 et 2007. Le taux brut a été de 1,74/100.000 avec un taux plus important chez l'homme que chez la femme. Le rapport standardisé de mortalité, après correction pour l'âge et le sexe, a augmenté de 0,54 (95% IC = .49-.59) en 1968 pour atteindre 1.26 (95% IC =1.20, 1.32) en 2007. Cette augmentation de mortalité est mieux expliquée par un effet dit cohorte, qui implique tous les sujets nés en même temps, plutôt que par un effet dit période. Le changement d'exposition à des toxiques environnementaux pourraient expliquer ces effets cohortes. Nous avons ensuite analysé les taux et les prédicteurs de survie au Centre SLA de la Salpêtrière en se focalisant sur la période 2002-2009 pour la survie et 1995-2009 pour les prédicteurs. Aucune variable n'est meilleure pour prédire la survie, mais une combinaison de variables (le début par les membres, la durée début des symptômes et première visite, et la force musculaire) est associée à une survie prolongée. Ce taux de survie a clairement augmenté depuis 2006.

Published
2012

37. Sclérose latérale amyotrophique : mortalité, facteurs prédictifs de la survie

Author

Gordon, Paul H., CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris VI, and Vincent MEININGER

Subjects
survie, épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, mortalité, maladie du motoneurone, prédicteurs de survie, sclérose latérale amyotrophique
Abstract

Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction of motor neurons, and to death of the patient in less than three years from symptom-onset. Better characterization of the epidemiology of ALS could improve understanding of the disease and lead to etiologic hypotheses, determine whether patterns of occurrence are changing, and show whether distinct phenotypes exist that could be examined for distinct causes. First, we examined the mortality rate from motor neuron disease in France from 1968 to 2007. The crude mortality rate over the study period was 1.74/100,000 person-years, and was higher in men than women. Mortality peaked between 75 and 79 years of age. The Standardized mortality ratio, after indirect standardization for age and gender, increased from 0.54 (95% CI = .49-.59) in 1968 to 1.26 (95% CI =1.20, 1.32) in 2007. The increasing mortality from MND was better explained by a cohort effect, which involves all individuals born at the same time, independent of their age at death, than by a period effect. Changing environmental exposures are a possible explanation for cohort effects, and could be examined in future studies. Next we analyzed survival rates and predictors of survival at the ALS Center, Salpêtrière Hospital, focusing on the survival rate during 2002-2009, and predictors of survival in 1995-2009. No single clinical factor best predicted survival, but a combination of variables (limb-onset, long duration between symptom-onset and first visit, and high muscle strength) were associated with longer survival. The survival rate improved significantly at the center after 2006.; La sclérose latérale amyotrophique ou SLA est une affection neurodegenerative conduisant à la mort des motoneurones, et responsable du décès des patients en moins de trois ans après la survenue des premiers symptômes. En l'absence de la découverte des causes chez la plupart des patients a considérablement pesé dans les difficultés que nous rencontrons pour découvrir un nouveau traitement. Une meilleure approche de l'épidémiologie pourrait permettre d'améliorer la connaissance de la maladie et pourrait offrir la possibilité de mieux formuler les hypothèses physio pathologiques possibles. Dans un premier temps, nous avons etudié le taux de mortalité de la SLA en France entre 1968 et 2007. Le taux brut a été de 1,74/100.000 avec un taux plus important chez l'homme que chez la femme. Le rapport standardisé de mortalité, après correction pour l'âge et le sexe, a augmenté de 0,54 (95% IC = .49-.59) en 1968 pour atteindre 1.26 (95% IC =1.20, 1.32) en 2007. Cette augmentation de mortalité est mieux expliquée par un effet dit cohorte, qui implique tous les sujets nés en même temps, plutôt que par un effet dit période. Le changement d'exposition à des toxiques environnementaux pourraient expliquer ces effets cohortes. Nous avons ensuite analysé les taux et les prédicteurs de survie au Centre SLA de la Salpêtrière en se focalisant sur la période 2002-2009 pour la survie et 1995-2009 pour les prédicteurs. Aucune variable n'est meilleure pour prédire la survie, mais une combinaison de variables (le début par les membres, la durée début des symptômes et première visite, et la force musculaire) est associée à une survie prolongée. Ce taux de survie a clairement augmenté depuis 2006.

Published
2012

38. A common functional allele of the Nogo receptor gene, reticulon 4 receptor (RTN4R), is associated with sporadic amyotrophic lateral sclerosis in a French population

Author

Amy, Maïté, primary, Staehlin, Oliver, additional, René, Frédérique, additional, Blasco, Hélène, additional, Marouillat, Sylviane, additional, Daoud, Hussein, additional, Vourc’h, Patrick, additional, Gordon, Paul H., additional, Camu, William, additional, Corcia, Philippe, additional, Loeffler, Jean-Philippe, additional, Palkovits, Miklós, additional, Sommer, Wolfgang H., additional, and Andres, Christian R., additional

Published
2015
Full Text
View/download PDF

44. Untargeted 1H-NMR metabolomics in CSF: Toward a diagnostic biomarker for motor neuron disease

Author

Blasco, Hélène, primary, Nadal-Desbarats, Lydie, additional, Pradat, Pierre-François, additional, Gordon, Paul H., additional, Antar, Catherine, additional, Veyrat-Durebex, Charlotte, additional, Moreau, Caroline, additional, Devos, David, additional, Mavel, Sylvie, additional, Emond, Patrick, additional, Andres, Christian R., additional, and Corcia, Philippe, additional

Published
2014
Full Text
View/download PDF

48. Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry

Author

Blasco, Hélène, primary, Corcia, Philippe, additional, Pradat, Pierre-François, additional, Bocca, Cinzia, additional, Gordon, Paul H., additional, Veyrat-Durebex, Charlotte, additional, Mavel, Sylvie, additional, Nadal-Desbarats, Lydie, additional, Moreau, Caroline, additional, Devos, David, additional, Andres, Christian R., additional, and Emond, Patrick, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results